Patent · US Active

Pyridone derivative pharmaceutical composition and preparation method thereof

US10709699B2 · kind B2 · utility

5Cited by

0References

17Claims

0Family size

Assignee

JIANGSU HENGRUI MEDICINE CO., LTD. · CN

Inventors

Huan Ding · Lo Wu, CN
Daimei Zhang · 安丰镇, CN

Key dates

Filing date	Nov 24, 2017
Grant date	Jul 14, 2020
Priority date	—
Expiry date	Nov 24, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/4866
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a pyridone derivative pharmaceutical composition and a preparation method thereof. In particular, provided are a pharmaceutical composition containing a pyridone derivative or a pharmaceutically acceptable salt thereof and the preparation method thereof. The pharmaceutical composition contains an active ingredient 2-((2-fluoro-4-iodophenyl)amino)-1-methyl-4-((6-methylpyridin-3-yl)oxy)-6-oxo-1,6-di hydropyridine-3-carboxamide or a pharmaceutically acceptable salt thereof, and hydroxypropyl methylcellulose, and the pharmaceutical composition has good dissolution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.